Wojciech Laska - User's Blog

Dr Barbara Czech-Szczapa

We are on the frontline of the epidemiological front

Dr Barbara Czech-Szczapa, epidemiologist, Head of the Epidemiology Laboratory at the Medical University of Poznań: Poland, as a border country, is on the front line of the EU epidemiological front. Russia's armed attack on Ukraine, the difficult humanitarian situation in the areas covered by the...

July 4, 2022

Matching drugs to DNA is the "new era of medicine"

Scientists from the British Pharmacological Society and the Royal College of Physicians say a genetic test can predict how a given drug will work in the human body. The field of drug matching to DNA is known as pharmacogenomics.

March 29, 2022

Research Findings: Mother-to-child transmission of COVID-19 is possible but rare

The SARS-CoV-2 virus that causes COVID-19 infection can be passed from mother to baby before, during and after birth, new research shows - but such events are rare.

March 18, 2022

Will "behavioral psychedelics" help patients make a lasting, positive change?

Psychedelics may find use in treating anxiety, depression, stress disorders, addiction, and other mental health problems. However, for this to happen, rigorous research and application methods must be developed.

March 17, 2022

WHO has confirmed 16 reports of attacks by Russians on medical facilities in Ukraine

Catherine Smallwood, a senior emergency officer at the WHO's regional office for Europe, said at the conference that the WHO had verified 16 attacks on medical infrastructure in Ukraine, which killed 9 and injured 16 people. She said attacks took place in different directions of the attack and on...

March 10, 2022

Tissues grown in vitro will help replace live animals in research into heart disease

Work is underway to open up new research opportunities for heart regeneration while reducing the use of live animals in research.

March 9, 2022

Promising results from a preclinical study for the treatment of pancreatic cancer

A preclinical study in mice suggests that blocking a major inflammatory pathway that is activated in pancreatic cancer makes tumors vulnerable to chemotherapy and a type of immunotherapy that stimulates the immune system's T cells to attack the cancer cells. The therapy more than doubled survival...

March 8, 2022

An appeal to abandon individual drug collections for the fighting Ukraine

The Ministry of Health, the Chief Pharmaceutical Inspector and the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products are calling for the resignation of individual drug collections for the fighting Ukraine, in favor of organized or coordinated actions as part of...

March 4, 2022

The combination of the three drugs prolongs the survival of patients with metastatic, hormone-sensitive prostate cancer

The results of an international, randomized, double-blind, placebo-controlled phase III clinical trial indicate that the addition of the androgen receptor inhibitor darolutamide to androgen deprivation therapy and chemotherapy prolongs the survival of men with metastatic, hormone-sensitive...

Feb. 22, 2022

A breach in the protective barrier of pancreatic cancer

Our immune system has the potential to find and destroy cancer cells. However, cancer cells use tricks to avoid the immune system's response. Professor Douglas Fearon of the Cold Spring Harbor Laboratory and ZhiKai Wang of the University of Science and Technology of China found one such trick....

Feb. 18, 2022

Purring to your health

February 17 is World Cat Day. Cats accompany humans for at least 9 thousand. years. They are the most popular pets in the world and the boarding community literally fell in love with them. Cat keepers say that "you have to earn their love, but it's definitely worth it." What do the research say...

Feb. 17, 2022

Psilocybin is effective in the long-term treatment of major depression

Previous research by scientists from Johns Hopkins Medicine found that treatment with psilocybin relieved symptoms of major depressive disorder in adults for up to a month. Now, the results of a follow-up study indicate that psychotherapy-assisted treatment with psilocybin produces significant...

Feb. 17, 2022

ThinkstockPhotos-461866395-jajnik-ovary-ovarian-cancer-rak-jajnika

The new drug combination is effective in patients with advanced ovarian cancer

New research shows that ixabepilone together with bevacizumab (IXA + BEV) is a well-tolerated, effective combination in the treatment of platinum-resistant ovarian cancer / taxanes. The use of the combination IXA + BEV gave better results in both progression-free time and overall survival than...

Feb. 15, 2022

A new robotic surgery technique has the potential to improve the outcomes of cancer surgery

Scientists at National Robotarium, a partnership between Heriot-Watt University and Edinburgh University, industrial partners and Edinburgh clinicians are developing a new robotic surgery technique to improve cancer outcomes and patient care . The groundbreaking method has won a £ 1.25 million...

Feb. 14, 2022

The study shows the declining efficacy of the third dose of mRNA vaccines

A nationwide study by the U.S. Centers for Disease Control and Prevention (CDC) is the first to show resistance to severe COVID-19 begins to wane 4 months after receiving the third dose of mRNA vaccine

Feb. 14, 2022

CAR-T therapy: Over 10-year remission in two patients with leukemia

A study published by Nature found that the use of CAR-T cell gene therapy was effective in treating leukemia and keeping the disease in remission for over 10 years in two people.

Feb. 11, 2022

Fourth dose of the COVID-19 vaccine. Over a thousand people with referrals.

The Ministry of Health issued a recommendation according to which people over 12 years of age with immune disorders can receive a fourth dose of the COVID-19 vaccine at least five months apart from the previous dose.

Feb. 11, 2022

Annual flu vaccination in children strengthens their future immunity

Scientists have found that children who receive the seasonal flu vaccine for years produce antibodies that also provide them with greater protection against new strains, including those that can cause a pandemic.

Feb. 4, 2022

A new treatment pathway for advanced triple negative breast cancer

New research shows that inhibition of the CECR2 gene prevents the progression or metastasis of triple-negative breast cancer.

Feb. 3, 2022

WHO: the new Omikron sub-variant does not cause more severe disease

Last week, the Statens Serum Institut, which monitors infectious diseases in Denmark, reported that the new Omikron BA.2 sub-variant is 1.5 times more infectious than the original BA.1 strain. Although a study by Danish scientists showed that BA.2 is much more infectious than BA.1 among both...

Feb. 2, 2022

Author of entries: Wojciech Laska